AID/APOBEC deaminases and cancer

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Mutations are fundamental to evolution and genetic diseases, including cancer.
• Deep-sequencing reveals non-random mutation signatures in human cancers, challenging the notion of random DNA damage.
• The AID/APOBEC family of DNA deaminases is increasingly implicated in these non-random mutations.

Purpose of the Study:

• To review the role of mutagenic events caused by AID/APOBEC deaminases in cancer development.
• To explore how these enzymes contribute to genomic instability and clonal evolution in cancer.

Main Methods:

• Review of existing literature on DNA deaminases, mutation signatures, and cancer genomics.
• Analysis of studies linking AID/APOBEC activity to specific mutation patterns in cancer genomes.

Main Results:

• APOBEC enzymes, involved in immunity, can cause DNA deamination leading to mutations.
• These mutations exhibit non-random patterns, including strand-bias and motif-specificity.
• APOBEC-driven mutagenesis is proposed as a mechanism contributing to cancer development and evolution.

Conclusions:

• AID/APOBEC deaminases are significant contributors to the mutagenic landscape of cancer.
• Their activity can induce collateral genomic damage, promoting cancer progression.
• Understanding APOBEC's role is crucial for cancer research and therapeutic strategies.